|Dosage Form||Package Information||Links|
|CAPSULE, DELAYED RELEASE||1 BOTTLE in 1 BOX (21130-019-14) > 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE||Label Information|
|CAPSULE, DELAYED RELEASE||3 BOTTLE in 1 BOX (21130-019-42) > 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE||Label Information|
|CAPSULE, DELAYED RELEASE||2 BOTTLE in 1 BOX (21130-019-28) > 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE||Label Information|
Clostridium difficile-associated diarrhea (CDAD): A diagnosis of CDAD should be considered for patients taking Proton Pump Inhibitors (PPIs) who develop diarrhea that does not improve. Symptoms include:
Patients should seek immediate care from a healthcare professional if these symptoms do not go away while taking this medication.
Allergy alert: Do not use if you are allergic to lansoprazole.
In case of overdose, get medical help or contact a Poison Control Center right away.
14-Day Course of Treatment
Repeated 14-Day Courses (if needed)
Compare to Active Ingredient in Prevacid®24HR*
Delayed-Release Capsules, USP 15 mg
SEE NEW WARNINGS INFORMATION
CAPSULES 14-DAY COURSE OF TREATMENT
KEEP THE CARTON AND PACKAGE INSERT. THEY CONTAIN IMPORTANT INFORMATION.
Do not use if inner foil seal imprinted with "Sealed For Your Protection" or dark blue to black gelatin band around the center of each capsule is missing or broken.
DISTRIBUTED BY SAFEWAY INC.
P.O. BOX 99, PLEASANTON, CA 94566-0009
1-888-SAFEWAY / www.safeway.com
Product of India
*This product is not manufactured or distributed by Takeda Pharmaceuticals North America, Inc., owner of the registered trademark Prevacid®, or by Novartis Consumer Health, Inc., distributor of the Prevacid®24HR product.
lansoprazole capsule, delayed release
|Labeler - Safeway, Inc. (009137209)|
|Registrant - P and L Development of New York Corporation (800014821)|